Boxer Capital LLC 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-15 9:59 pm Purchase | 2024-10-10 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 6,534,298 12.400% | 85,939 (+1.33%) | Filing |
| 2024-02-08 5:10 pm Purchase | 2024-02-06 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 6,448,359 12.300% | 125,000 (+1.98%) | Filing |
| 2022-06-15 7:11 pm Unchanged | 2022-06-13 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 6,323,359 15.100% | 0 (Unchanged) | Filing |
| 2021-09-24 4:30 pm Purchase | 2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 6,323,359 14.900% | 6,323,359 (New Position) | Filing |